Source: Annual Congress 2005 - Resistant and MDR tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Macri, O. Moldovan, A. Hristea, C. Stefani (Bucharest, Romania). Attempt to estimate risk factors for drug resistance (DR) in tuberculosis. Eur Respir J 2005; 26: Suppl. 49, 4134

Member's Comments

No comment yet.

Related content which might interest you: The risk of ineffective MDR/XDR TB treatment, based on bedaquilin: factors and their influence Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 Frequency of side effects among patients with drug resistant tuberculosis (DR-TB) by resistance pattern in a high burden country. Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 Outcome of multidrug resistant tuberculosis (MDR-TB) treatment with possible influencing factors Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011 Recent transmission of drug resistant M. tuberculosis in Latvia Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis Year: 2005 The problem of multi-drug resistant (MDR)-TB Source: Annual Congress 2005 - PG10 - The management of tuberculosis: tradition and novelties Year: 2005 HIV and multidrug-resistant tuberculosis: overlapping risk factors Source: Eur Respir J 2015; 45: 567-569 Year: 2015 The impact and cost-effectiveness of strategies to detect drug-resistant tuberculosis Source: Eur Respir J 2012; 39: 626-634 Year: 2012 Contact screening in tuberculosis. Can we identify those with higher risk? Source: Annual Congress 2012 - Tuberculosis: epidemiological and public health features Year: 2012 Identification of high risk factors for development of active tuberculosis in children with latent tuberculosis infections Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017 Is it smoking a risk factor in tuberculosis? Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010 Smoking is a risk factor for TB infection, but is it an additional mortality risk? Source: Annual Congress 2011 - Management of tuberculosis Year: 2011 Contact screening in tuberculosis: can we identify those with higher risk? Source: Eur Respir J 2013; 41: 758-760 Year: 2013 Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis Source: Eur Respir J 2016; 48: 1751-1763 Year: 2016 The prevalence of latent pulmonary tuberculosis infection (LTBI) in low and high risk populations in Ireland Source: Eur Respir J 2005; 26: Suppl. 49, 425s Year: 2005 Pyrosequencing(PSQ) in early diagnosis of CNS tuberculosis and determining drug resistance. Source: International Congress 2019 – Tuberculosis: from basic science to patient care Year: 2019 Risk factors of development of amplified Mtb resistance to antituberculous drugs Source: Eur Respir J 2005; 26: Suppl. 49, 652s Year: 2005 Predicting outcomes and drug resistance with standardised treatment of active tuberculosis Source: Eur Respir J 2010; 36: 870-877 Year: 2010 Who is at risk for active tuberculosis? Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches Year: 2003 The problem of one drug resistance in tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 858s Year: 2006